Semaglutide Dosing in Units: Concentration Explained

*This article is for education only and does not constitute medical advice, and it is not a dosing recommendation. Semaglutide is a prescription medication. Dose selection and any change in dose, concentration, or product form belong with your licensed prescriber and pharmacist. The worked examples below are illustrations of arithmetic, not instructions for any individual patient. Do not start, stop, adjust, or convert a dose on your own.*

---

The Question Behind the Question

A patient opens a new vial, reads the label, and sees a number that does not match last month. The prescription has not changed. The pharmacy has not changed. The dose is the same on paper. But the syringe now needs a different amount of liquid to deliver it.

That is the moment patients search for semaglutide dosing in units.

The confusion is structural rather than personal, and it comes from two systems of measurement meeting at the same syringe. Your prescription is written in milligrams, because milligrams are the unit that describes how much drug you are getting. Your syringe is marked in units, because units describe how far you pull the plunger. Something has to translate between them, and that something is the concentration printed on the vial.

When concentration is constant, that translation is invisible and nobody thinks about it. When concentration varies, which it does on the compounded side of this market, the translation becomes the single most important number in the process. The U.S. Food and Drug Administration has issued dosing-error safety communications to health care providers and compounders describing exactly this failure: reports of patients receiving incorrect doses of compounded injectable semaglutide, traced to variable concentration and inconsistent labeling, with consequences ranging from severe gastrointestinal effects to treatment failure.

This page explains how the arithmetic works, why the same dose draws differently on two vials, what the regulatory alerts actually say, and what to verify before every injection. It does not tell you what dose to take. That conversation belongs with your prescriber.

---

Milligrams Are the Dose. Units Are the Volume.

Start by separating two ideas that get collapsed in casual conversation.

Milligrams describe quantity of drug. When your prescriber titrates you to 1 mg weekly, that 1 mg is the pharmacological dose. It is the number that matters clinically, the number the trials are expressed in, and the number that should stay stable while you remain at a given step of the schedule.

Units on an insulin syringe describe volume of liquid. A standard U-100 insulin syringe is calibrated so that 100 units equal 1 mL. That calibration has nothing to do with semaglutide. It is a syringe standard, borrowed because these syringes are widely available, precisely marked, and familiar to patients.

The bridge between the two is concentration, written as mg/mL: milligrams of drug per milliliter of fluid.

So the relationship has three parts, and any two of them determine the third:

✦concentration (mg/mL), printed on the vial
✦dose (mg), chosen by your prescriber
✦volume (mL), which is what the syringe measures

The formula, stated plainly: volume in mL equals dose in mg divided by concentration in mg/mL. And because units scale linearly with volume at U-100, units equal mL multiplied by 100.

That is the entire arithmetic. It is not hard. It is easy to get wrong anyway, which is why the alerts exist.

---

Two Vials, One Dose, Different Syringes

The fastest way to see why concentration matters is to hold the dose fixed and change the concentration.

Suppose a prescriber has chosen a 1 mg weekly dose, and the patient's first vial is labeled 5 mg/mL.

✦Volume: 1 mg divided by 5 mg/mL equals 0.2 mL
✦Units at U-100: 0.2 mL multiplied by 100 equals 20 units

Now the refill arrives from the same pharmacy, dispensed at 2.5 mg/mL instead. The dose on the prescription is unchanged at 1 mg.

✦Volume: 1 mg divided by 2.5 mg/mL equals 0.4 mL
✦Units at U-100: 0.4 mL multiplied by 100 equals 40 units

Same dose. Same drug. Twice the liquid. Twice the units.

Now run the error in the other direction, which is the one that causes harm. The patient, used to drawing 20 units, keeps drawing 20 units from the new vial because the prescription still says 1 mg and they have not registered the concentration change.

✦Volume drawn: 20 units equals 0.2 mL
✦Drug delivered: 0.2 mL multiplied by 2.5 mg/mL equals 0.5 mg

They intended 1 mg and got half of it. The opposite mix-up, drawing the old unit count when concentration has gone up, delivers a double dose. Both directions are represented in the reported errors.

Vial concentration	1 mg dose in mL	1 mg dose in units (U-100)
1 mg/mL	1.0 mL	100 units
2.5 mg/mL	0.4 mL	40 units
5 mg/mL	0.2 mL	20 units
10 mg/mL	0.1 mL	10 units
20 mg/mL	0.05 mL	5 units

Read the table across the top row. As concentration rises, the volume for the same dose falls, and the unit count falls with it. Nothing about the dose changed. Only the concentration did.

This table is arithmetic, not guidance. Its purpose is to show you why the number on the syringe is not the number on the prescription, and why the vial label is not optional reading.

---

Why Compounded Semaglutide Concentrations Vary

Brand-name semaglutide arrives in a pen with a fixed, manufacturer-controlled concentration. The dose is selected by clicking, the device delivers the volume, and the patient never sees mg/mL. That design deliberately removes the conversion step.

Compounded semaglutide works differently. It is a pharmacy-made preparation assembled from purchased active pharmaceutical ingredient rather than supplied by the manufacturer, and it is dispensed as a vial or a prefilled syringe. Two structural facts follow.

First, concentration is a pharmacy-level decision, not a standard. Different compounding pharmacies fill at different concentrations. The same style of vial from two pharmacies may be labeled 5 mg/mL and 10 mg/mL, delivering the same dose at very different volumes.

Second, concentration can change between batches from the same pharmacy, particularly as supply arrangements, labeling practices, and regulatory posture shift. A patient who has drawn the same number of units for months is exactly the patient least likely to notice that the concentration line moved.

The regulatory context makes this sharper rather than looser. When the FDA determined the semaglutide injection shortage resolved in early 2026, the broad compounding window that existed during the shortage narrowed, and the agency has proposed removing semaglutide, tirzepatide, and liraglutide from the bulk-substances list used by larger-scale compounders. Whatever a given patient's situation is after those changes, the practical lesson does not change: on the compounded side of this market, the patient or their caregiver is often the last check in a chain that has several places to go wrong.

---

What the FDA Actually Said

The agency's compounding risk communications and drug safety alerts tell a consistent story across multiple documents.

The reported harm. Patients received incorrect doses of compounded injectable semaglutide, with consequences including overdoses (severe gastrointestinal effects, hypoglycemia) and underdoses (treatment failure, because a patient believed they were on a therapeutic dose and were not).

The mechanism. Concentration and labeling confusion. Compounded products prepared at variable concentrations, with dosing expressed in different units across products and labels, including mg, mL, pen clicks, and insulin-style units. Mixing those systems invites conversion errors during measurement and administration.

The directed fix. The alerts instruct compounders to standardize labeling and concentration expression, and direct providers to verify concentration and dose units before administering or dispensing.

There is no version of this where the alert was about a rare edge case. Dosing error of this kind is a systems problem, and the system spans the pharmacy, the prescriber, the label, and the kitchen table.

---

The Four-Number Check Before Every Injection

What follows is a verification habit, not a dosing instruction. Four numbers, stated out loud before the injection, in a single sentence.

1. The concentration on the vial. Read the mg/mL line off the actual vial in your hand, not from memory or from last month's box. If you are using a compounded product, this is the number most likely to have changed silently.

2. The dose your prescriber set, in mg. This is the clinical number. If it has not changed, the sentence's middle section will match last month.

3. The volume that dose implies, in mL. Derived from the first two numbers by division. If you cannot do this confidently, that is information: ask your prescriber or pharmacist to write it down for you rather than estimating.

4. The units to draw, on the specific syringe you were given. Confirm the syringe is actually U-100 before assuming the conversion. A different syringe standard changes the arithmetic entirely.

Stated as a sentence, it sounds like this: the vial is 5 mg/mL, my dose is 1 mg, which is 0.2 mL, drawn as 20 units. If any one of those four numbers is different from what you expected, stop and call before injecting. Nothing about a GLP-1 requires an immediate injection at the moment of discovery.

Three habits support the check:

✦Keep the vial label visible while drawing, rather than pulling from a numbered organizer where the labels are face-down.
✦Re-read the label at every refill, deliberately. The refill you did not think about is the one where concentration changed.
✦Write the four numbers down once and keep the note with your supplies, so the comparison takes seconds rather than minutes.

---

What to Ask, and Who to Ask

The arithmetic above is arithmetic. Everything clinical in it belongs to someone licensed to make clinical decisions, and that is the point of asking rather than inferring.

Questions worth putting to your prescriber:

✦What is my dose in mg, and is that a change from last month?
✦What concentration was I dispensed, and is it expected to stay the same at refills?
✦Can you write the volume and the units on the prescription or the dispensing label?
✦If my concentration changes, who tells me, and how?

Questions worth putting to your pharmacist:

✦Is this U-100, and is that the syringe this volume assumes?
✦Can you show me the conversion once, in person or on video?
✦Does my dispensing label state concentration, dose in mg, volume, and units together?

A prescriber or pharmacist who cannot or will not answer these has told you something useful. The FDA alerts already established that these four numbers are the failure point. There is no good reason for the people managing your care to be unable to state them.

For the broader regulatory picture behind compounding in this market, our guide to what compounded semaglutide is and how its legal footing changed covers the shortage era and what replaced it. For the labeled titration schedules themselves, see tirzepatide dosing and how titration works. If you are weighing a lower-than-labeled starting approach, GLP-1 microdosing and what the evidence shows is the relevant page. And if you are comparing how you obtain therapy at all, our Dallas clinic versus telehealth cost comparison walks through where care actually differs.

---

The Takeaway That Matters

Your dose is measured in milligrams. Your syringe is measured in units. Concentration is the number that connects them, and on the compounded side of this market, concentration is not guaranteed to hold still.

That produces one habit worth keeping: before every injection, read the concentration off the vial, restate the dose in mg, derive the volume, and confirm the units. Four numbers, one sentence, ten seconds. If any of them is not what you expected, call your prescriber before you inject rather than after.

Individual results vary, and nothing here is a prediction about your own response to therapy. Decisions about your dose, your product form, and your monitoring belong with a licensed healthcare provider who knows your history.

---

Frequently Asked Questions

Why is my semaglutide dose in units when my prescription says milligrams?

Because those are two different things. Milligrams describe how much semaglutide is in the dose. Units describe how far you pull the plunger on the syringe, and that distance depends on the concentration of the vial. Concentration is the bridge: it converts the mg your prescriber chose into the units you draw. If the concentration changes and the units do not, the dose in mg changes with it.

What does mg/mL mean on a semaglutide vial?

It is the concentration: milligrams of semaglutide per milliliter of liquid. A 5 mg/mL vial contains 5 mg in every 1 mL. A 10 mg/mL vial contains 10 mg in the same 1 mL of fluid, so the same volume carries twice the drug. This is the number that determines how many units equal your dose, and it is the number that must match across every refill.

How do I convert mg to units on an insulin syringe?

Units scale with volume on a standard U-100 insulin syringe, where 100 units equal 1 mL. So the unit count is the volume in mL multiplied by 100. At 5 mg/mL, a 1 mg dose is 0.2 mL, drawn as 20 units. At 2.5 mg/mL, the same 1 mg dose is 0.4 mL, drawn as 40 units. Same dose, twice the units. That is why the vial concentration, not the prescription alone, determines what you draw. Confirm your specific conversion with your prescriber or pharmacist before injecting.

Are compounded semaglutide concentrations standardized?

No, and that is the central practical problem. Brand-name semaglutide pens deliver a fixed, manufacturer-controlled concentration. Compounded preparations are filled by individual pharmacies at concentrations that vary between pharmacies and can change between batches from the same pharmacy. The FDA has issued dosing-error safety communications describing reported overdoses and underdoses traced specifically to variable concentration and inconsistent labeling of compounded injectable semaglutide.

What are the signs I may have taken the wrong dose?

An excessive dose typically produces intensified gastrointestinal effects such as severe nausea, vomiting, diarrhea, or abdominal pain, and can be associated with hypoglycemia. An inadequate dose produces no dramatic symptoms at all, which is the harder problem: treatment simply does not work and the patient assumes the medication failed. Either way, contact your prescriber rather than adjusting anything yourself, and seek urgent care for severe or persistent symptoms.

Should I draw my own units or use a prefilled pen?

That is a clinical decision that belongs with your prescriber and pharmacist, and it depends on the product form you were dispensed, your comfort with measurement, and your history. Prefilled pens with fixed doses remove the conversion step entirely; vials and syringes require the patient to do it correctly every time. If you are on a vial, ask for in-person or video injection training rather than learning from a package insert. Do not change product forms on your own.

What should I confirm with the pharmacy at every refill?

Four things: the concentration printed on the vial, the dose expressed in mg, the volume that corresponds to it, and the units on the syringe you were given. State it back in one sentence before you inject: the vial is this many mg/mL, my dose is this many mg, which is this many mL, drawn as this many units. If any of the four numbers changed since last month without a prescriber telling you to expect it, stop and call before injecting.

Ready to Start Your Protocol?

Schedule a virtual consultation with a licensed physician to determine if peptide therapy is right for you.

Start Your Consultation

This article is for educational purposes only and does not constitute medical advice. Information on this website should not be used to diagnose, treat, or prevent any medical condition. Consult with a licensed physician before starting any new therapy.

Semaglutide Dosing in Units: Why the Same Dose Looks Different on Two Vials